Literature DB >> 17881459

Structural and functional interactions between FXYD5 and the Na+-K+-ATPase.

Irina Lubarski1, Steven J D Karlish, Haim Garty.   

Abstract

FXYD5 is a member of a family of tissue-specific regulators of the Na(+)-K(+)-ATPase expressed in kidney tubules. Previously, we have shown that FXYD5 interacts with the alphabeta-subunits of the Na(+)-K(+)-ATPase and increases its V(max) (Lubarski I, Pihakaski-Maunsbach K, Karlish SJ, Maunsbach AB, Garty H. J Biol Chem 280: 37717-37724, 2005). The current study further characterizes structural interaction and structure-function relationships of FXYD5. FXYD5/FXYD4 chimeras expressed in Xenopus laevis oocytes have been used to demonstrate that both the high-affinity association with the pump and the increase in V(max) are mediated by the transmembrane domain of FXYD5. Several amino acids that participate in the high-affinity interaction between FXYD5 and the alpha-subunit of the Na(+)-K(+)-ATPase have been identified. The data suggest that different FXYD proteins interact similarly with the Na(+)-K(+)-ATPase and their transmembrane domains play a key role in both the structural interactions and functional effects. Other experiments have identified at least one splice variant of FXYD5 with 10 additional amino acids at the COOH terminus, suggesting the possibility of other functional effects not mediated by the transmembrane domain. FXYD5 could be specifically bound to wheat germ agglutinin beads, indicating that it is glycosylated. However, unlike previous findings in metastatic cells, such glycosylation does not evoke a large increase in the size of the protein expressed in native epithelia and X. laevis oocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881459     DOI: 10.1152/ajprenal.00367.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  14 in total

Review 1.  The Na-K-ATPase α₁β₁ heterodimer as a cell adhesion molecule in epithelia.

Authors:  Olga Vagin; Laura A Dada; Elmira Tokhtaeva; George Sachs
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

2.  Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.

Authors:  Shiri Moshitzky; Carol Asher; Haim Garty
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

Review 3.  Mechanism of noradrenaline-induced stimulation of Na-K ATPase activity in the rat brain: implications on REM sleep deprivation-induced increase in brain excitability.

Authors:  Birendra Nath Mallick; Sudhuman Singh; Abhishek Singh
Journal:  Mol Cell Biochem       Date:  2009-10-13       Impact factor: 3.396

4.  Post-transcriptional control of Na,K-ATPase activity and cell growth by a splice variant of FXYD2 protein with modified mRNA.

Authors:  Kathleen J Sweadner; Jennifer L Pascoa; Cynthia A Salazar; Elena Arystarkhova
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

Review 5.  The role of AMPK in regulation of Na+,K+-ATPase in skeletal muscle: does the gauge always plug the sink?

Authors:  Sergej Pirkmajer; Metka Petrič; Alexander V Chibalin
Journal:  J Muscle Res Cell Motil       Date:  2021-01-04       Impact factor: 2.698

6.  The O-glycosylated ectodomain of FXYD5 impairs adhesion by disrupting cell-cell trans-dimerization of Na,K-ATPase β1 subunits.

Authors:  Elmira Tokhtaeva; Haying Sun; Nimrod Deiss-Yehiely; Yi Wen; Pritin N Soni; Nieves M Gabrielli; Elizabeth A Marcus; Karen M Ridge; George Sachs; Mónica Vazquez-Levin; Jacob I Sznajder; Olga Vagin; Laura A Dada
Journal:  J Cell Sci       Date:  2016-05-03       Impact factor: 5.285

7.  S163 is critical for FXYD5 modulation of wound healing in airway epithelial cells.

Authors:  Timothy J Miller; Pamela B Davis
Journal:  Wound Repair Regen       Date:  2008 Nov-Dec       Impact factor: 3.617

8.  FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells.

Authors:  Irina Lubarski-Gotliv; Carol Asher; Laura A Dada; Haim Garty
Journal:  J Biol Chem       Date:  2016-03-22       Impact factor: 5.157

9.  Expression and clinical significance of FXYD3 in endometrial cancer.

Authors:  Yifei Li; Xia Zhang; Shuwen Xu; Jing Ge; Jing Liu; Lin Li; Guiying Fang; Yali Meng; Hongzhen Zhang; Xiaofeng Sun
Journal:  Oncol Lett       Date:  2014-05-23       Impact factor: 2.967

Review 10.  FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease.

Authors:  Irina Lubarski Gotliv
Journal:  Front Cell Dev Biol       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.